Kaye Randall - Insider Stock Trading - OpenInsider

CIK: 1350416 - Address: 4275 Executive Square, Suite 950, La Jolla, CA 92037

14 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
S	%ret	1	1	11	0	2	6	12	17	-3	6
S	%wins				73	73	55	45	40	50	56

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
10/16/24 16:40	10/15/24	LBPH	Longboard Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	CMO	S.d	-984	59.04	0	-17	-48	18	D
9/16/24 19:36	9/16/24	LBPH	Longboard Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	CMO	S.d	-527	31.64	0	-17	-48	18	D
8/13/24 18:01	6/25/24	LBPH	Longboard Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	CMO	S.dm	-581	34.64	0	-17	-32	36	M
9/13/11 17:01	9/9/11	AVNR	Avanir Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	SVP,Chie	S	-275	2.75	6	-100	-56	78	D	26	3	-32	-23	-26	9	-2	-2	-1	-2	8	-24
1/7/11 17:23	1/5/11	AVNR	Avanir Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	SVP,Chie	S	-41	4.05	11	-10	-5	178	D	826	120	28	28	-1	12	1	3	1	5	-2	-5	-17	-48
12/8/10 12:33	12/6/10	AVNR	Avanir Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	SVP,Chie	S	-38	3.80	16	-10	-5	190	D	999	106	56	43	34	-16	-9	-5	-1	-3	10	3	-2	-34
11/8/10 21:26	11/5/10	AVNR	Avanir Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	SVP,Chie	S	-48	4.76	31	-10	-5	200	D	999	158	76	46	43	48	77	7	-4	-4	-23	-17	-18	-45
10/5/10 20:25	10/5/10	AVNR	Avanir Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	SVP,Chie	S	-32	3.23	6	-10	-4	240	D	444	65	24	8	15	19	5	-3	0	7	41	31	25	-15
9/8/10 21:48	9/7/10	AVNR	Avanir Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	SVP,Chie	S	-27	2.70	4	-10	-4	251	D	192	38	33	23	-19	-13	-7	-5	-1	-1	16	42	29	1
8/20/10 19:18	8/18/10	AVNR	Avanir Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	SVP,Chie	S	-108	3.08	4	-35	-12	261	D	220	41	59	24	-10	-7	-8	-4	-5	0	-1	49	31	-8
8/9/10 19:01	8/5/10	AVNR	Avanir Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	SVP,Chie	S	-33	3.28	5	-10	-3	296	D	253	51	87	27	22	1	1	-2	-1	-5	-17	46	24	3
7/9/10 17:34	7/7/10	AVNR	Avanir Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	SVP,Chie	S	-30	3.02	5	-10	-3	306	D	234	70	72	9	37	15	19	4	6	-1	-2	-5	26	5
6/8/10 20:21	6/7/10	AVNR	Avanir Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	SVP,Chie	S	-119	2.38	3	-50	-14	317	D	86	96	26	15	-25	-16	-3	-8	12	23	41	21	76	84
9/15/09 21:18	9/15/09	AVNR	Avanir Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kaye Randall	CA	O	SVP,Chie	S	-4	2.10	4	-2	0	398	I	-4	145	380	39	3	14	13	9	-1	0	0	-13	0	27

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact